[go: up one dir, main page]

BR0302183A - Compound, pharmaceutical composition and use of a compound - Google Patents

Compound, pharmaceutical composition and use of a compound

Info

Publication number
BR0302183A
BR0302183A BR0302183A BR0302183A BR0302183A BR 0302183 A BR0302183 A BR 0302183A BR 0302183 A BR0302183 A BR 0302183A BR 0302183 A BR0302183 A BR 0302183A BR 0302183 A BR0302183 A BR 0302183A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
salt
hindol
pyrrol
Prior art date
Application number
BR0302183A
Other languages
Portuguese (pt)
Inventor
Julie Kay Bush
Margaret Mary Faul
Susan Marie Reutzel-Edens
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to BR0302183A priority Critical patent/BR0302183A/en
Publication of BR0302183A publication Critical patent/BR0302183A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA E USO DE UM COMPOSTO". A presente invenção refere-se a sal mono--hidrocloreto de 2,5-diona-3-(1-metil-1H-indol-3-il)-4-[1-(piridin-2-ilmetil)piperidin-4-il]-1 Hindol-3-il]-1H-pirrol cristalino, uma formulação farmacêutica contendo dito sal e a métodos de tratar câncer e inibir crescimento de tumor usando dito sal."COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND". The present invention relates to 2,5-dione-3- (1-methyl-1H-indol-3-yl) -4- [1- (pyridin-2-ylmethyl) piperidin-4-monohydrochloride salt Crystalline-yl] -1-Hindol-3-yl] -1H-pyrrol, a pharmaceutical formulation containing said salt and methods of treating cancer and inhibiting tumor growth using said salt.

BR0302183A 2002-07-31 2003-07-10 Compound, pharmaceutical composition and use of a compound BR0302183A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0302183A BR0302183A (en) 2002-07-31 2003-07-10 Compound, pharmaceutical composition and use of a compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0203041 2002-07-31
BR0302183A BR0302183A (en) 2002-07-31 2003-07-10 Compound, pharmaceutical composition and use of a compound

Publications (1)

Publication Number Publication Date
BR0302183A true BR0302183A (en) 2004-11-16

Family

ID=33453184

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0302183A BR0302183A (en) 2002-07-31 2003-07-10 Compound, pharmaceutical composition and use of a compound

Country Status (1)

Country Link
BR (1) BR0302183A (en)

Similar Documents

Publication Publication Date Title
UA93351C2 (en) Phthalazine derivatives as parp inhibitors
MY141739A (en) Substituted quinazoline derivatives as inhibitors of aurora kinases
PL406680A1 (en) Tyrosine kinase inhibitors
DE50311898D1 (en) FREDERICAMYCIN DERIVATIVES AS A MEDICAMENT FOR TUMOR TREATMENT
GEP20053530B (en) Tyrosine Kinase Inhibitors, Pharmaceutical Compositions Containing Them and Use Thereof
BR0212042A (en) Compound, pharmaceutical composition, method of treating or preventing disease, and use of a compound
EA200501849A1 (en) DERIVATIVES OF PYRAZOLOHINAZOLINE: METHOD FOR OBTAINING AND USING AS KINAZ INHIBITORS
TR200302242T2 (en) Pyrolopyrimidines as protein kinase inhibitors
RS20050522A (en) Protein kinase inhibiting tricyclic compounds that increase the effects of anti-neoplastic agents and therapeutic radiation
BR0308243A (en) Compound, pharmaceutical formulation, and, methods of treating diabetes, alzheimer's disease, and inhibiting gsk-3 in a mammal
GB0112348D0 (en) Compounds
BR0309343A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
BR0309342A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
ATE238981T1 (en) ANTITUMOR ACTIVES
CA2461622A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
ECSP055537A (en) 2,5-DIONA-3- MONOCLORHYDRATE (1-METHYL-1H-INDOL-3-IL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-IL] -1H-INDOL-3-IL ] -1H-CRYSTAL PIRROL
BR0209128A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds
BR0311491A (en) Compound, Pharmaceutical Composition, Use of a Compound, and, Therapeutic Method to Treat Cancer in a Mammal
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
MXPA04005809A (en) Protein kinase inhibitors.
EA200501233A1 (en) 4-AMINOPYRIMIDIN-5-OH
BR0309996A (en) Compound, pharmaceutical composition, method of treating or ameliorating proliferative diseases or conditions, use of a compound, and method of treating or ameliorating inflammatory diseases
BR0311970A (en) New compounds, their use and preparation
SE0104326D0 (en) Therapeutic heterocycles
BR0302183A (en) Compound, pharmaceutical composition and use of a compound

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)